Researchers have developed a highly accurate blood test for amyotrophic lateral sclerosis (ALS), potentially reducing diagnosis times and improving patient outcomes.
Scientists at Weill Cornell Medicine in Qatar have developed a comprehensive molecular map of the human body, integrating data from multiple ‘omics’ platforms to create a powerful new research tool.
A broadly neutralising antibody capable of protecting against all known SARS-CoV-2 variants and related coronaviruses has been discovered by researchers at the University of Texas at Austin.
New research reveals that patients with stable coronary artery disease who quit smoking at any point after diagnosis can reduce their risk of major cardiovascular events by nearly 50%. The study, presented at ESC Congress 2024, also found that merely reducing smoking habits had minimal impact on cardiovascular risk.
Researchers at Weill Cornell Medicine have utilised advanced machine learning techniques to identify three distinct subtypes of Parkinson’s disease, potentially paving the way for more personalised treatment approaches.
A groundbreaking neuroimaging study has identified distinct patterns of brain activation associated with various forms of love, offering new insights into the neural underpinnings of this complex emotion.
Researchers from German universities have identified a new class of molecules that could pave the way for innovative tuberculosis treatments, offering hope in the face of rising antibiotic resistance.
Groundbreaking research led by Karolinska Institutet reveals significantly elevated risks of mortality and morbidity for pregnant women with epilepsy and their babies, emphasising the need for specialised care throughout pregnancy and beyond.
Researchers have developed an innovative, low-cost wound dressing that harnesses water-activated electrical stimulation to significantly accelerate healing in diabetic mice, potentially offering a game-changing solution for chronic wound treatment.
Researchers at Amsterdam University Medical Center have uncovered a novel mechanism explaining diaphragm weakness in mechanically ventilated intensive care patients, potentially paving the way for new treatments to aid ventilator weaning.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
© Suhre/Halama Labs
Pärttyli Rinne et al 2024, Aalto University
© Rajaram Kaveti